Previous Page  19 / 42 Next Page
Information
Show Menu
Previous Page 19 / 42 Next Page
Page Background

Page 129

conferenceseries

.com

Volume 6

Research & Reviews: Journal of Material Sciences

ISSN: 2321-6212

Advanced Materials 2018

September 04-06, 2018

September 04-06, 2018 | Zürich, Switzerland

21

st

International Conference on

Advanced Materials & Nanotechnology

Controlled antibiotic-loaded, drug-eluting implants for osteomyelitis

Daniel Li

1, 2

, Yaoyi Huang

2

, Hong Shen

2

, Yunlong Ma

2

, Decheng Wu

2

and

Yuanzheng Ma

2

1

Northwestern University, USA

2

309

th

Hospital of the PLA, China

B

one infections are disastrous complications associated with orthopaedic implants such as prosthetic joints and fracture

fixation devices. Local inflammation results osteolysis and destruction of the surrounding soft tissues. Management of such

infections remains a significant challenge to clinicians, especially given the global rising prevalence of total joint arthroplasty.

Current treatment regimens involve surgical debridement along with a prolonged course of antibiotics, which lacks bacterial

and risks systematic toxicity to the patient. The efficacy of localized drug delivery, such as antibiotic-infused bone cement, is

limited due to having only an initial burst release effect without a controlled, sustainable release profile. The ability to load

antibiotics within a hydrogel scaffold to act as a drug delivery mechanism demonstrates promise in addressing this issue. In this

study, we describe the fabrication of a vancomycin-loaded, polyethylene glycol (PEG) based hydrogel film covalently attached

to titanium implant surfaces. Alginate microspheres were incorporated into the hydrogel to better control the rate of drug

release. Specifically, this attenuates the initial burst release and delivers the drug at a more uniform rate by inhibiting hydrogel

swelling. The resulting implants proved to be biocompatible and demonstrated minimal burst release, offering a consistent rate

of drug elution for approximately four weeks

in vitro

. The rate of drug release could also be controlled by adjusting the amount

of vancomycin loaded and hydrogel thickness. Material analysis characterized vancomycin dispersion kinematics as a function

of the fabrication process. Antibiotic-loaded hydrogel coatings for titanium implants offer a unique drug delivery mechanism

that maintains a sustained rate of drug release.

In vivo

studies are necessary to determine biodegradative properties of the

material and the extent of antimicrobial activity against targeted organisms.

Recent Publications

1. Butler B A, Fitz D W, Lawton C D, Li D, Balderama E S and Stover M D (2018) Early diagnosis of septic arthritis in

immunecompromised patients. Journal of Orthopaedic Science 23(3):542-545.

2. Li D, Pengfei L, Linfeng F, Huang Y, Yang F, Mei X and Wu D (2017) The immobilization of antibiotic-loaded polymeric

coatings on osteoarticular ti implants for the prevention of bone infections. Biomaterials Science 5(11):2337–2346.

3. Li D, Li L, Ma Y, Zhuang Y, Li D, Shen H, Wang X, Yang F, Ma Y and Wu D (2017) Dopamine-assisted fixation of drug-

loaded polymeric multilayers to osteoarticular implants for tuberculosis therapy. Biomaterials Science 5(4)730-740.

4. Kuiken T A, Bennet B A, Sharkey T, Ivy A D, Li D and Peabody T D (2017) Novel intramedullary device for lengthening

transfemoral residual limbs. Journal of Orthopaedic Surgery and Research 12:53.

5. Fu S, Rossero J, Chen C, Alzgheir R, Li D and Takoudis C (2017) On the wetting behavior of ceria thin films grown by

pulsed laser deposition. Applied Physics Letters 110:8.

Biography

Daniel Li has completed his Undergraduate degree in Materials Science and Engineering at University of Illinois. He conducted research under John Rogers

Research Group investigating novel biodegradable electronics. He has participated in a wide variety of both basic and clinical research regarding biomaterials in

the context of orthopaedic applications, such as the use of hydrogels as a novel drug-eluting mechanism to combat osteomyelitis and tuberculosis infection. He

has spent significant time overseas in the orthopaedics department at the 309

th

Hospital of the PLA in Beijing, China, working under the team of Dr Yuanzheng Ma.

Currently, he is performing clinical outcomes research at Northwestern University regarding the evaluation of prosthetic joint infection.

Daniel.li1@northwestern.edu

Daniel Li et al., Res. Rev. J Mat. Sci. 2018, Volume 6

DOI: 10.4172/2321-6212-C3-021